Palisade Bio Inc PALI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:40 PM EDT
3.27quote price arrow down-0.11 (-3.25%)
Volume
129,994
52 week range
3.00 - 16.02

...

Loading . . .
  • Open3.39
  • Day High3.40
  • Day Low3.26
  • Prev Close3.38
  • 52 Week High16.02
  • 52 Week High Date03/22/21
  • 52 Week Low3.00
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap23.94M
  • Shares Out7.32M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change-37.5

KEY STATS

  • Open3.39
  • Day High3.40
  • Day Low3.26
  • Prev Close3.38
  • 52 Week High16.02
  • 52 Week High Date03/22/21
  • 52 Week Low3.00
  • 52 Week Low Date09/24/20
  • Market Cap23.94M
  • Shares Out7.32M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change-37.5

RATIOS/PROFITABILITY

  • EPS (TTM)-4.05
  • P/E (TTM)-0.81
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-10.804M
  • ROE (MRQ)-124.01%
  • Revenue (MRQ)10,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-146,355.70%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Palisade Bio Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Palisade Bio, Inc, formerly Seneca Biopharma, Inc., is a biopharmaceutical company. The Company is focused on developing therapies that helps patients with acute and chronic gastrointestinal problems from post-operative digestive enzyme damage. Its product candidate, LB1148, is a Phase III-ready protease inhibitor which is developed to reduce abdominal adhesions and help restore bowel function following surgery. It is engaged in developing oral product candidates to treat...
James Neal
Chairman
Dane Saglio CPA
Chief Executive Officer
Thomas Hallam
Chief Executive Officer
Matthew Kalnik Ph.D.
President
Address
20271 Goldenrod Ln Ste 2024
Germantown, MD
20876
United States

Top Peers

SYMBOLLASTCHG%CHG
AMBS
Amarantus Bioscience Holdings Inc
0.0051-0.0013-20.3125%
TPST
Tempest Therapeutics Inc
15.46-0.32-2.03%
TLOG
TetraLogic Pharmaceuticals Corp
0.017-0.0066-27.9661%
SNNAQ
Sienna Biopharmaceuticals Inc
0.0104+0.0003+2.51%
PSTV
Plus Therapeutics Inc
1.92-0.26-11.93%